Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MDR1 mRNA, transcribed from the ABCB1 gene (NCBI Gene ID: 5243), is the genetic template for P-glycoprotein (P-gp), a member of the ATP-binding cassette (ABC) transporter family (UniProt: P08183). This mRNA is a primary driver of multidrug resistance (MDR) in cancer, as its overexpression leads to an abundance of P-gp, which actively effluxes a wide variety of chemotherapeutic agents from the cytoplasm (PubMed: 25653465). Beyond its role in malignancy, MDR1 mRNA is expressed in normal tissues such as the liver, kidneys, and the endothelial cells of the blood-brain barrier (BBB), where it serves a protective role by limiting the entry of toxins into sensitive organs (PubMed: 11470988). Therapeutic targeting of MDR1 mRNA using small interfering RNAs (siRNAs) or antisense oligonucleotides (ASOs) aims to silence the production of P-gp, thereby restoring the efficacy of chemotherapy in resistant tumors (PubMed: 30234144). However, such interventions pose significant safety risks, including the potential for increased systemic toxicity of co-administered drugs and the compromise of the BBB, which can lead to neurotoxicity. Monitoring MDR1 mRNA levels via RT-qPCR is often used as a biomarker to predict or evaluate drug resistance in clinical settings.
RNA interference (RNAi) or antisense-mediated mRNA degradation and translational repression.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on ATP-binding cassette sub-family B member 1 mRNA (MDR1 mRNA).